Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06735885 · ClinicalTrials.gov registry record · NA

fMRI Neurofeedback With Matter Neuroscience App

A NA study of Depression and Depression Mild, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT06735885 is a NA study of Depression and Depression Mild that is actively recruiting participants, run by Stanford University. The registered enrollment target is 240 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06735885, a NA study of Depression and Depression Mild, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

Study will utilize an app, Matter Neuroscience, designed to help users with depression understand positive emotions and the neurotransmitters that create them. We hope to learn the safety and efficacy of neurofeedback for treating depression and lay the groundwork for a pivotal clinical trial.

Interventions

  • DEVICE Matter Neuroscience App
  • OTHER Stock Photos
  • OTHER No Home Training
  • DEVICE Personal Photos
  • OTHER Home Training

Study Locations (1)

California

  • Stanford University Brain Stimulation Lab - Stanford

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2025-08-12
Est. Completion 2028-06-15
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT06735885

The ClinicalTrials.gov registry entry for NCT06735885 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 5 interventions - of which Matter Neuroscience App is the first listed.

NCT06735885 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06735885 about?

NCT06735885 is a clinical study titled "fMRI Neurofeedback With Matter Neuroscience App". Study will utilize an app, Matter Neuroscience, designed to help users with depression understand positive emotions and the neurotransmitters that create them. We hope to learn the safety and efficacy of neurofeedback for treating depression and lay the groundwork for a pivotal clinical trial.

What is the current status of trial NCT06735885?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2025-08-12. Estimated completion is 2028-06-15.

What conditions does trial NCT06735885 study?

This clinical trial studies the following conditions: Depression, Depression Mild, Depression Moderate.

What interventions are being tested in trial NCT06735885?

The interventions under investigation include: Matter Neuroscience App (DEVICE), Stock Photos (OTHER), No Home Training (OTHER), Personal Photos (DEVICE), Home Training (OTHER).

Who is sponsoring clinical trial NCT06735885?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06735885 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.